Company: BBVXF
Filing Date: 2025-07-31
Form Type: 6-K
Source: 0000842180-25-000033
Chunk: 115

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-07-31
Form: 6-K
Chunk 115
---
228 |     |   1,185 |     |      30 |     |      14 |     |                        |     |      -9 |     |      -1 |     |      -1 |     |      -8 |     |                 |     |   1,219 |     |   1,184 |     |      29 |     |       6 |
| Total ⁽⁴⁾                     |     |                |     | 438,285 |     | 393,887 |     |  30,267 |     |  14,131 |     |                        |     | -11,621 |     |  -2,378 |     |  -1,818 |     |  -7,425 |     |                 |     | 426,663 |     | 391,508 |     |  28,449 |     |   6,706 |
| Of which: individual          |     |                |     |         |     |         |     |         |     |         |     |                        |     |  -1,379 |     |     -20 |     |    -332 |     |  -1,027 |     |                 |     |         |     |         |     |         |     |         |
| Of which: collective          |     |                |     |         |     |         |     |         |     |         |     |                        |     | -10,243 |     |  -2,359 |     |  -1,487 |     |  -6,397 |     |                 |     |         |     |         |     |         |     |         |

(1) Spain includes all the countries where BBVA, S.A. operates.

(2) Turkey includes all the countries in which Garanti BBVA operates.

(3) In South America, BBVA Group operates in Argentina, Colombia, Peru and Uruguay.

(4) The amount of the accumulated impairment includes the provisions recorded for credit risk over the remaining expected lifetime of purchased financial instruments. Those provisions were determined at the moment of the Purchase Price Allocation (PPA) and were originated mainly in the acquisition of Catalunya Banc S.A. (as of June 30, 2025, the remaining balance was €86 million). These valuation adjustments are recognized in the consolidated income statement during the residual life of the instrument or applied as allowances in the value of the financial instrument